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Abstract
.
COVID-19 also known as coronavirus disease of 2019 is a viral illness caused by novel
coronavirus SARS-CoV2 that was discovered in December 2019 in Wuhan, China. To date,
there have been over 250 million cases worldwide. The severity of COVID-19 ranges from mild
symptoms to critical illness warranting hospitalization within an intensive care unit to death.
Current treatment modalities include supportive cares, monoclonal antibodies, interleukin
inhibitors, convalescent plasma, therapeutic anticoagulants, anti-inflammatory medications
and/or corticosteroids. A common complication due to COVID-19 is acute respiratory failure
resulting in pulmonary insult which start as cough but progress to the need for supplemental
oxygen and/or mechanical ventilation. There are varying modalities to provide supplemental
oxygen as well as processes to support such processes including proning. Patients that become
critically ill typically require increased amounts of supplemental oxygen to avoid hypoxia which
included early intubation. Based on a literature review, the recommendations have shown that
early intubation may not be key and that critically ill patients should be maintained on alternative
oxygen-supplying modalities to avoid hypoxia and potential intubation. For patients who
warranted intubation, literature reveals that timing of intubation did not have significant impact
on clinical outcomes. Based on the literature, an algorithm called Ventnet, has been developed
and should be utilized to assist in prediction of intubation in patients with acute respiratory
distress syndrome secondary to COVID-19.
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Introduction
In December 2019, a plethora of pneumonia cases emerged in Wuhan, China rapidly
spreading worldwide causing a pandemic. The virus causing this type of pneumonia was found
to be severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 also known as COVID19). As of November 2021, COVID-19 has caused over 5 million deaths worldwide
(Worldometer, 2021). Despite a significant amount of research and the fact that COVID-19 is a
viral process, there is no curative treatment for COVID-19. There are supportive treatment
methods including corticosteroids, therapeutic anticoagulants, anti-inflammatory medications,
monoclonal antibodies, interleukin inhibitors and convalescent plasma which have been utilized
and have been shown to decrease the severity and duration of symptoms of COVID-19 (Gupta et
al., 2020). In December 2020, vaccines for COVID-19 became available in the United States.
Priority was given to healthcare workers and high-risk patients such as those with comorbidities,
eventually being offered to the public, greater than 5 years of age. Given the respiratory
compromise secondary to the COVID-19 disease process, many patients require supportive
cares, medications, antivirals, and pulmonary support. Those who require pulmonary support,
may require supplemental oxygen via a simple nasal cannula but pulmonary status can progress
in severity to the point in which mechanical ventilation is warranted. The need for mechanical
ventilation carries its own risks and benefits. Such as ventilator induced injury, ventilator
associated pneumonia, sedation, and associated delirium (Shashikumar et al.,2020). Although
patients may require mechanical ventilation, there lacks supportive evidence as to the timing of
such an intervention and how that affects clinical outcomes.
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Background and Rationale
COVID- 19 is a viral illness that became apparent in December 2019 and progressed to a
worldwide pandemic in the subsequent months. COVID-19 is transmitted via droplet
transmission which consists of direct spray of large droplets onto the mucous membranes of a
host when an infected individual sneezes, coughs, or talks. COVID-19 can affect any individual,
whether it be a healthy child or frail, elderly adult, causing the individual to develop symptoms
of COVID-19 that can range from mild to severe in nature (Berlin, 2020). Atkins et al. (2020)
studied preexisting comorbidities and their association with COVID-19. Those with a prior
diagnosis of dementia, type 2 diabetes, chronic obstructive pulmonary disease, pneumonia,
depression, atrial fibrillation, and hypertension were the most likely to be hospitalized if
diagnosed with COVID-19. COVID-19 presents with similar symptoms of upper respiratory
infection including fever, chills, cough, sore throat, loss of taste or smell, fever, fatigue, muscle
aches, headache, congestion or runny nose, nausea, vomiting, and/or diarrhea. With COVID-19,
there is a wide spectrum of severity of symptomology from being asymptomatic to those
warranting hospitalization and potentially care in the intensive care unit (ICU).
The National Institutes of Health (NIH) developed criteria for identifying the severity of
COVID-19 illness according to clinical manifestations (2021). To be considered asymptomatic
individuals test positive using a virologic or an antigen test but remain without symptoms (NIH,
2021). Mild symptomology includes those with symptoms such as fever, cough, sore throat,
malaise, headache, muscle pain, nausea, vomiting, diarrhea, loss of taste and smell (NIH,2021).
Typically, patients of mild symptomology category lack any significant pulmonary symptoms
including shortness of breath, dyspnea, or abnormal chest imaging (NIH, 2021). Moderate
symptomology includes those with lower respiratory disease on clinal assessment or imaging
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that shows some pneumonia (NIH, 2021). Those with moderate symptomology typically have an
oxygen saturation of equal to or greater than 94% without supplemental oxygen (NIH, 2021).
Severe symptomology is defined as those who have an oxygen saturation equal to or less than
94% without supplemental oxygen, a ratio of arterial partial pressure of oxygen to fraction of
inspired oxygen less than 300 mm Hg, a respiratory rate more than 30 breaths per minute, and/or
lung infiltrates in more than 50% of lung space (NIH, 2021). Those with severe symptomology
have the potential to progress to acute respiratory failure, septic shock or multiple organ failure
(NIH, 2021).
As a result of COVID-19, there is the possibility that patients could develop pneumonia
which can lead to hypoxemic respiratory failure resulting in acute respiratory distress syndrome
(ARDS) (Berlin et al., 2020). Berlin et al. defines ARDS as “the acute onset of bilateral
infiltrates, severe hypoxemia, and lung edema that is not fully explained by cardiac failure or
fluid overload” (2020). As COVID-19 progresses through its course, patients develop ARDS
typically have a tenuous pulmonary status and mechanical intubation is most often warranted. Of
the critically ill patients admitted to the ICU with COVID-19, 67-85% develop ARDS (Pan et al,
2020). Based on the literature, mechanical ventilation was performed if the patient clinically
decompensated warranting pulmonary support although is some studies, intubation was delayed
due to being considered an aerosolized procedure. Given COVID-19 is still rather new and there
is limited data, timing of intubation and mechanical ventilation remains unclear (Berlin et al.,
2020).
Patients with severe symptomology related to COVID-19 were more likely to require
intubation due to their tenuous respiratory status. Autopsies performed on patients with severe
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COVID-19 showed diffuse alveolar damage, the hallmark sign of ARDS (Berlin et al., 2020). In
many cases of ARDS, which has many similarities to COVID-19 pneumonia, literature shows
providing early intubation decreases lung trauma, which ais in the healing process (Berlin et al,
2020). With early intubation, protective ventilation strategies can be utilized which include low
tidal volumes and moderate positive end-expiratory pressure or PEEP are the basis of treatment
for ARDS (Ferrando et al., 2020). In patients who developed ARDS, delaying of intubation
increased a patients’ mortality risk (Matta et al., 2020). By delaying intubation whether it be in a
patient with severe COVID-19 or without COVID-19 but experiencing an ARDS type situation,
can cause increased self-induced lung injury. (Tobin et al., 2020). This brings forward the
thought for comparison of ARDS in a non-COVID-19 to severe COVID-19 with an ARDS type
clinical picture and further thoughts if the disease processes should be treated the same in regard
to timing of intubation.
During the early COVID 19 pandemic, there was a perceived shortage of mechanical
ventilators which led to a drastic change in how healthcare providers determined when a patient
warranted intubation. Initially, COVID-19 patients were intubated once their need for
supplemental oxygen exceeded more than 6 liters via nasal cannula. With the perceived shortage
of mechanical ventilators, healthcare providers were forced to utilize subsequent modalities of
supplemental oxygen delivery including non-invasive measures such as high flow nasal cannula
(HFNC), continuous positive airway pressure or bilevel positive airway pressure (Schünemann et
al., 2020). According to Matta, “the optimal threshold regarding when to intubate patients with
COVID-19 pneumonia remains unclear” (2020).
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Purpose
The primary purpose of this integrative literature review was to assess the literature to
determine if early versus delayed intubation in patients with COVID-19 has an impact on overall
patient outcomes. Identifying the optimal timing for intubation and mechanical ventilation is
imperative for patients with COVID-19 due to the high mortality rate among those critically ill
with the viral process.
Clinical Question
Based on the provided information, a clinical question was developed to guide the
literature search. The clinical question to guide this integrated literature review is the following:
For patients with severe COVID-19, does timing of intubation and mechanical ventilation affect
overall outcomes? The term overall outcomes could be defined as a range of aspects which could
include from survival at 28 days post admission, development of ARDS, comparing SOFA
scores, oxygenation, ICU days/length of stay, ventilator-free days and P/F ratios, and mortality.

Method of Inquiry
An integrative literature review of the current literature was the method of inquiry
conducted for this scholarly inquiry paper. This method gives a comprehensive review of the
evidence to aid in a better understanding of the clinical question and knowledge of the
interventions available. Given this topic, COVID-19, is a very up and coming topic, much of the
literature is current although smaller studies. The outcome of the literature review is to provide
recommendations to the clinical question discussed.

Literature Review
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Introduction
A literature review was completed using multiple search engines with multiple different
key words. This method was utilized to find a larger understanding of the research studies
present on the subject of COVID-19, the timing of intubation with initiating mechanical
ventilation and the effect on clinical outcomes.
Search Strategy
Multiple search engines were used to perform a thorough literature search on the topic.
Continuous searches were performed throughout the development of this paper as COVID-19
has been an everchanging topic. Search engines used included: Cochrane library, Google
Scholar, Pubmed, Ebscohost, CINAHL. Keywords to guide this search included: COVID-19,
covid, intubation, timing, early, late, ARDS, and criteria. The searches took place between
December 7, 2020, through April 1, 2021. All articles used were published between 2020 and
2021 and written in the English language. See Table 1 for search engines used.
Studies chosen for this literature review can be viewed in Table 2. Articles that were
excluded were studies including patients with mild COVID-19 and not treated with mechanical
ventilation. Levels of evidence included in this review ranged from I to IV including one
systematic review, meta-analysis, and multiple retrospective studies.
Levels of Evidence
Articles were chosen, reviewed, and then rated on levels of evidence based on the Ackely
et al. (2008) evidence framework. See table 3. The levels of evidence used in the literature
review are as follows: one systemic review and meta- analysis (level I) and 13 retrospective
cohort studies (level IV).
Review of Evidence
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Themes
Common themes were found throughout the literature to help guide the clinical question
whether early versus late intubation has an impact in overall clinical outcomes of patients with
severe COVID-19. The term clinical outcomes could be defined as a range of clinical outcomes
including survival at 28 days post COVID-19 diagnosis, to development of ARDS, comparing
SOFA scores, oxygenation status, ICU days/length of stay, ventilator-free days and P/F ratios,
and mortality. However, mortality as an outcome for patients with severe COVID-19 was the
most frequent theme in articles chosen related to COVID-19 and intubation. The two most
common themes used to separate the articles were as follows, intubation timing makes no
difference in overall outcomes and timing of intubation affects mortality.
Intubation Timing Makes No Difference in Mortality
In review of COVID- 19 and timing of intubation, mortality is a repeating theme.
Hernandez et al. (2020), Hyman et al. (2020), Lee et al. (2020), Matta et al. (2020), Patoutsi et al.
(2021), and Siempos et al.(2020), all found no evidence that increased amount of time to
intubation had any effect on the mortality of these patients. According to Siempos et al. (2020),
the early intubation strategy was not associated with fewer ventilator days or fewer ICU days.
With this evidence, Matta et al. (2020) suggests that COVID-19 could be managed similarly to
hypoxic respiratory failure not caused by COVID-19. While continuing to point out that the
optimal management of COVID-19 has not been established, Paptousi et al. (2021) suggests a
“wait-and-see approach” which could lead to fewer intubations. Lee et al. (2020) also supported
the theme that early intubation was not associated with improved survival, nor did it show the
late intubation increased mortality. This information may help with the limited medical resources
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such as mechanical ventilators and personal protective equipment that was problematic early in
the COVID-19 pandemic.
Voshaar et al. (2021) encouraged conservative management of COVID-19 hypoxemia,
consisting of a primary goal of maintaining the patient’s own spontaneous breathing, if possible,
by using oxygen therapy, non-invasive ventilation, and patient positioning techniques such as
prone or lateral position. To decrease the mortality rate that was a trend with COVID-19 patients,
an escalation protocol was developed that only increased respiratory support with increased
dyspnea, allowing permissive hypoxemia (Voshaar et al., 2021). The study noted that invasive
ventilation may correct the initial hypoxemia in the short term but can cause a ventilatory
associated lung injury or oxygen induced ARDS at any point during the mechanical ventilation
(Voshaar et al., 2021). The study found that this more restrictive use of intubation as a more
beneficial strategy for severe COVID-19 patients resulting in a lower rate of mortality and fewer
patients needing supplemental oxygen at discharge (Voshaar et al., 2021).
Timing of Intubation affects Mortality
On the other side of the spectrum, Rhee et al. (2020) found that significant hypoxemia
and a worsened ratio of arterial oxygen partial pressure (PaO2 in mmHg) to fractional inspired
oxygen also known as a P/F ratio surrounding intubation, the more likely the patient was to
experience cardiac arrest peri-intubation. A limitation of this study was that it was performed
from data collected early in the pandemic and ways of preoxygenating the patient prior to
intubation safely without viral aerosolization of disease to the staff was unknown. Therefore,
preoxygenation was not done prior to intubation thus increasing the likelihood of peri-intubation
complications such as cardiac arrest. That fact may have increased the number of cardiac arrests
and complications surrounding intubation early in the pandemic. Hyman et al. (2020) concluded
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that intubation earlier in the hospital course may be associated with improved outcomes” (p. 7).
This conclusion was made from data that each additional day after admission, before being
intubated, was significantly associated with higher in-hospital death rates (Hyman et al., 2020).
Again, this data was taken from early on in the pandemic, January 30, 2020, to May 1, 2020,
when safety of noninvasive measures of respiratory support was less known. The use high- flow
nasal cannula, continuous positive airway and bilevel positive airway pressure was not as
common due to the unknown of how to protect the exposure of healthcare workers against the
viral aerosolization of these devices. It is also noted in this study that the lack of ICU beds and
ventilators available may have played a part in the increased amount of mortality and time to
intubation thus patients who warranted earlier intubation could possibly have experienced better
outcomes due to receiving better care (Arulkumaran et al., 2020).
Pandya et al. (2021) revealed data that supported patients with increased mortality had
delayed and prolonged intubation and prolonged ICU stays. Also noted in this study was worse
compliance on ventilator, increased fraction of inspired oxygen (FI02) needs and increased age
thus whether the increased mortality rate is caused by delayed intubation or disease progression
is unknown (Pandya et al., 2021).
Zhang et al. (2020) also found that increased time to intubation increased mortality. The
study took this data farther by discovering that when these patients had an Acute Physiology and
Chronic Health Evaluation II (APACHE II) score less than 10 or a pneumonia severity index
(PSI) of less than 100, intubating in less than 50 hours from admission could decrease mortality
to 60% or less (Zhang et al., 2020). The APACHE II score is based form 0-100, the higher the
score the more the mortality rate increases (Zhang et al., 2020). The PSI score is the estimated
severity of pneumonia which is used to predict mortality risk (Zhang et al., 2020). Showing that
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each case needs to be looked at individually to take in for account individual risk factors and
comorbidities.
A Deeper Look into Mortality
Zuccon et al. (2020) and Gupta et al. (2020) were two articles that looked deep into
factors that increased mortality. In the Zuccon et al. (2020) study, multiple factors that did affect
mortality were noted, including onset of symptoms, age, and number of days in the ICU. In
addition to those, Gupta et al. (2020) also noted that males, patients with higher body mass index
(BMI), active cancer, presence of hypoxemia, liver, and kidney dysfunction, level of dysfunction
not noted, and being admitted to a hospital with minimal ICU beds available had a higher risk of
mortality. Zuccon et al. (2020) found that the most severely ill COVID-19 patients had diffuse
alveolar damage, thrombotic microangiopathy along with an associated focus of alveolar
hemorrhage, which progressed into organ failure going into a phase of lung consolidation,
interstitial and intralobular fibrosis. Zuccon et al. (2020) continues to note that these processes
are not well understood, and it is unknown if this is a part of the super inflammation by release of
cytokines or the mediated effect of COVID-19. Neither of these studies focused on the timing of
intubation with patients with COVID-19 or how this affected mortality.
Need an Algorithm
Shashikumar et al. (2020) researched the best possible way to predict the need for
mechanical ventilation in patients with COVID-19. They concluded that “a generalizable and
transparent deep-learning algorithm improves on traditional clinical criteria to predict the need
for mechanical ventilation in hospitalized patients, including those with COVID-19. Such an
algorithm may help clinicians with optimizing timing of endotracheal intubation, better
allocation of mechanical ventilation resources and staff and improve patient care” (Shashikumar
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et al., 2020, p. 3). The developed algorithm was created with information taken directly from the
electronic health record of no COVID-19 and COVID-19 (Shashikumar et al., 2020). The goal of
this model was to end emergent intubations and to avoid unnecessary intubation (Shashikumar et
al., 2020). Shashikumar et al. (2020) was able to identify the top 15 factors most contributed to
the high-risk score 12 hours prior to intubation. These factors included respiratory rate, oxygen
saturation, heart rate, total bilirubin, platelet count, temperature, aspartate aminotransferase
(AST), fraction of inspired oxygen FIO2, any change in platelets, fibrinogen, phosphate, any
change in temperature, any change in alkaline phosphate, and any change in white blood count
which is calculated in 4 to 24 hour increments. See appendix A which shows the VentNet
algorithm the intubation prediction model example that spans 67 hours. This guides providers to
when intubation need is coming.
Summary of Evidence
Going forward with synthesizing the evidence, the literature supports the need for a better
system to determine the need for intubation for severe COVID-19 patients. There are many
articles, Hernandez et al. (2020), Hyman et al. (2020), Lee et al. (2020), Matta et al. (2020),
Patoutsi et al. (2021), and Siempos et al. (2020), that all support theory that intubation timing
makes no difference in clinical outcomes. Voshaar et al. (2021) suggested that permissive
hypoxemia should allow for delayed intubation until clinical presentation deteriorates. Rhee et al.
(2020) suggests the opposite, which is that lower oxygen levels cause an increase cardiac arrests
and complications surrounding intubation. Data from Pandya et al. (2021) and Zang et al. (2020)
supports that timing of intubation does make a difference in rates of mortality. This could also
be dependent on other factors such as disease progression, age, or comorbidities. Gupta et al.
(2020) and Zuccon et al. (2020) dive deeper into the many other factors that affect mortality,
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suggesting timing of intubation not being one of them. Shashikumar et al. (2021) supports a
specific algorithm to determine need for intubation, streamlining the process.

Conceptual Framework
The conceptual framework most appropriate to guide the answer to this clinical question
would be the John Hopkins Nursing Evidence Based Practice Model (JHNEP). The JHNEP is
described as a “powerful problem-solving approach to clinical decision making” (Dang &
Dearholt, 2017). The model uses a three-step guide to problem solving, using the practice
question, evidence, and translation (PET) method (Dang & Dearholt, 2017). See appendix B to
see framework. The framework begins the process with the practice question which in this case
was related to the severe COVID-19 patients related to timing of intubation and the affect this
has on overall clinical outcomes. The next step is evidence for which the available evidence was
reviewed in detail, although limited, for guidance. Based on the evidence, there was not one clear
outcome that was found to be more superior than another. Research showed that there were more
factors that needed to be considered such as the patients hemodynamic status, pulse oximetry,
and levels such as oximetry, blood gas, and lower d-dimers which often predicted patient
mortality.
For the translation step, recommendation for changes in clinical practice are made based
on the evidence. After reviewing and synthesizing the evidence, there is not one clear
recommendation for practice. Although one promising piece of evidence was an algorithm called
VentNet that could be used to determine which patients are at highest risk for acute respiratory
failure or respiratory failure related to severe COVID-19. Permission was granted by John
Hopkins Nursing to utilize their model.
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Conclusion, Recommendations, Implications for Nursing
Introduction
The purpose of this integrative literature review was to determine if early versus delayed
intubation in severe COVID-19 patients would have an impact on overall clinical outcomes.
Identifying the optimal timing for intubation and mechanical ventilation for patients with severe
COVID-19 is important due to the high mortality rate among severe COVID-19 patients. This
knowledge could potentially improve mortality outcomes in severe COVID-19 patients. This
section will go over practice implications and provide recommendations on optimal timing of
intubation and mechanical ventilation of severe COVID-19 patients as well as the need for an
algorithm for timing of intubation of severe COVID-19 patients.
Conclusion
Ideal timing of intubation of severe COVID-19 patients to allow for the best possible
clinical outcomes is yet to be determined. Delayed intubation or lack of intubation can result in
an increase in mortality rates (Voshaar et al. 2021).
Implications for Nursing
Nurses are on the forefront when caring for patients, in this case, specifically those that
are severely ill with COVID-19. Nurses are the first to recognize a change in vital signs,
deterioration in clinical status, and the need to alert the medical team that the next necessary
steps will need to be taken to care for the patient, in this case, intubation. Given a lack of
supportive evidence to determine if early versus delayed intubation is more effective; an
algorithm could be developed that could not only guide healthcare providers, but nurses as well
could use the algorithm as a guide to alert a healthcare provider as to when a patient may warrant
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intubation versus relying on clinical judgement alone. This will aid in better communication
among nurses and healthcare providers as well as empower nurses to have a voice when caring
for these severely ill patients.
Recommendations
A recommendation for practice is for a specific algorithm aimed at patients with severe
COVID-19 to identify ideal intubation timing. By using Shashikumars’ et al. (2021) algorithm,
the need for intubation could be predicted within the 24 hours of the procedure occurring. The
algorithm is described as a generalizable and transparent deep learning process. Goals of the
algorithm model include minimizing the number of urgent intubations therefore reducing
hemodynamic instability (Shashikumar et al., 2021). The algorithm could assist in decreasing
unnecessary intubations, which itself carries risk such as a ventilator induced lung injury,
ventilator associated pneumonia and unnecessary sedation (Shashikumar et al., 2021).
The Shashikumars et al. (2021) algorithm takes input from the electronic medical record
to predict need for intubation. The variables used are all found in the electronic medical record
which consist of laboratory studies and vital signs. The VentNet algorithm was used in the
Shashikumars’ et al. study (2021). This algorithm outperformed other similar modalities in the
study (Shashikumars’ et al., 2021). The VentNet algorithm used in Shashikumars et al. (2021)
study uses 40 clinical variables including heart rate, pulse oximetry, temperature, systolic blood
pressure, mean arterial pressure, diastolic blood pressure, respiration rate and end tidal carbon
dioxide, laboratory values such as bicarbonate, measure of excess bicarbonate, fraction of
inspired oxygen or FiO2, pH, partial pressure of carbon dioxide from arterial blood, oxygen
saturation from arterial blood, aspartate transaminase, blood urea nitrogen, alkaline phosphatase,
calcium, chloride, creatinine, bilirubin direct, serum glucose, lactic acid, magnesium, phosphate,
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potassium, total bilirubin, troponin, hematocrit, hemoglobin, partial thromboplastin time,
leukocyte count, fibrinogen and platelets (Shashikumar et al., 2021). For each vital sign and
laboratory variable, the slope of change since its last measurement is included (Shashikumar et
al., 2021). This highly sensitive algorithm was able to provide a 24-hour prediction of intubation
needs for severe COVID-19 patients (Shashikumar et al., 2021).
As described in the literature review, outcomes for severe COVID-19 patients were not
worsened by delayed intubation. Maintaining these patients’ oxygen levels in any way possible
with non-invasive measures is best. By using the VentNet algorithm tool to predict intubation
needs in the next 24 hours, providers can avoid urgent intubations.
Summary
COVID-19 is a viral illness that emerged in December of 2019, turning into a world-wide
pandemic. Currently there is no curative treatment. There are pharmacologic interventions that
could shorten the duration and decrease severity of the illness. As of December 2020, COVID-19
vaccines were made available to help control the spread of COVID-19. Despite these
interventions, COVID-19 has not become obsolete. COVID-19 is still prevalent in a spectrum of
severity ranging from asymptomatic patients to those who are severely ill. Severely ill patients
with COVID-19 often require intubation but the timing of this procedure in this patient
population is not clear. A review of the literature shows that early intubation versus delayed
intubation does not influence mortality outcomes. In fact, some literature supported delayed
intubation with the end goal that patients may not need intubation at all. With implementation of
VentNet, an algorithm that takes vital signs and laboratory values into account, intubations could
be predicted within 24 hours of occurring. Therefore, decreasing unnecessary intubations and
urgent intubations all while decreasing mortality outcomes in severe COVID-19 patients.
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internal
medicine, 180(11),
1436-1446.
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kcom.wsuproxy.mn
pals.net/journals/ja
mainternalmedicin
e/articleabstract/2768602

“To assess factors
associated with
death and to
examine
interhospital
variation in
treatment and
outcomes for
patients with
COVID-19” (p.
1436).

2215 adults
diagnosed with
COVID-19

Multicenter cohort
study
Retrospective
control trial

Primary outcome:
Mortality rates at 28 days
of Intensive Care Unit
(ICU) admission

35.4% of patients (784) died
within the first 28 days of ICU
admission, 37.2% of patients
(607) remained hospitalized at
28 days. Causes of death were
respiratory failure (727
[92.7%]), septic shock (311
[39.7%]), and kidney failure
(295 [37.6%])

Intubation timing was not
considered as a factor of
death at 28 days
Factors associated with 28day death included age,
male gender, morbid
obesity, coronary artery
disease, cancer, acute organ
dysfunction, and admission
to a hospital with limited
intensive care unit beds.

Level IV

Pubmed

Intensive care units
in New York City,
NY and Seattle,
WA
-65 sites, from
March 4 to April 4,
2020

Those discharged prior to
28 day endpoints were
considered alive
Secondary outcomes:
Development of
respiratory failure, acute
respiratory distress
syndrome, congestive
heart failure, myocarditis,
pericarditis, arrhythmia,
shock, acute cardiac
injury, acute kidney
injury, acute liver injury,
coagulopathy, secondary
infection, and
thromboembolic events
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coronavirus
disease 2019
patients: a singlecenter cohort
study. Critical
care medicine. .
https://www-ncbinlm-nihgov.wsuproxy.mn
pals.net/pmc/articl
es/PMC7448713/

To determine the
impact of time to
intubation and use
of high-flow nasal
cannula on clinical
outcomes in
patients with
COVID-19

231 adult patients
with COVID-19

Retrospective
cohort study

Interventions included:

“Seventy-six patients (43.4%)
were intubated within 8 hours
of ICU admission, 57 (32.6%)
were intubated between 8 and
24 hours of admission, and 42
(24.0%) were intubated at
greater than or equal to 24
hours after admission” (p.1).

Neither time from ICU
admission to intubation nor
use of high-flow nasal
cannula use were associated
with increased mortality.
This study provides
evidence that COVID-19
respiratory failure can be
managed similarly to
hypoxic respiratory failure
of other etiologies.

Level IV

Pubmed

Six ICU settings
across four
university affiliated
hospitals in Atlanta,
Georgia

High-flow nasal cannula
alone
High-flow nasal cannula
followed by intubation
Intubation without
preceding high-flow nasal
cannula use
Patients intubated within
the first 8 hours of ICU
admission
Patients intubated within
8-24 hours of ICU
admission
Patients intubated after
24 horus of ICU
admission

Mortality did not differ by
timing of intubation (≤ 8 hr:
38.2%; 8–24 hr: 31.6%; ≥ 24
hr: 38.1%; p = 0.7),
“There was no difference in
initial static compliance,
duration of mechanical
ventilation, or ICU length of
stay by timing of intubation.
High-flow nasal cannula use
prior to intubation was not
associated with increased or
decreased mortality” (p.1).
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Egorova, N.N.,
Bassily-Marcus,
A., Kohli-Seth, R.,
Arvind, V.,
Chang, H.L., Lin,
H.M. & Levin,
M.A. (2020).
Timing of
intubation and inhospital mortality
in patients with
coronavirus
disease
2019. Critical care
explorations, 2(10
). https://wwwncbi-nlm-nihgov.wsuproxy.mn
pals.net/pmc/25rti
cular/PMC758741

“To examine
whether increasing
time between
admission and
intubation was
associated with
increased
mortality in
patients with
COVID-19 who
underwent
mechanical
ventilation”(p.1).

755 adult patients
diagnosed with
COVID-19

Retrospective
cohort study

Cox model was used to
evaluate the effect of time
to intubation on inhospital death.

“As of this time in follow-up,
121 patients (16%) who were
intubated and mechanically
ventilated had been discharged
home, 512 (68%) had died, 113
(15%) had been discharged to a
skilled nursing facility, and 9
(1%) remained in the hospital.
The median time from
admission to intubation was 2.3
days (interquartile range, 0.6–
6.3 d).

Intubation earlier in the
hospital course may be
associated with improved
survival.

Level IV

8/
Google Scholar

Five hospitals
within the Mount
Sinai Health System
in New York City,
NY.

Time zero was defined as
the time a patient was
first placed on invasive
mechanical ventilation.
still intubated, extubated,
or having had a
tracheostomy.

Each additional day between
hospital admission and
intubation was significantly
associated with higher inhospital death (adjusted hazard
ratio, 1.03; 95% CI, 1.01–
1.05)” (p.1).
The adjusted hazard ratio for
mortality was 1.03 (95% CI,
1.01–1.05) for each day of
delay in intubation following
initial hospital presentation

Patients who were extubated
after a more prolonged
course of mechanical
ventilation (> 3 to 4 weeks)
had a lower hazard ratio for
death relative to patients
who were on mechanical
ventilation for a shorter
duration.
The observations suggest
that supportive care
consisting of early
intubation and conservative
extubating strategy may be
associated with improved
outcomes.
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Lee, Y. H., Choi,
K.-J., Choi, S. H.,
Lee, S. Y., Kim,
K. C., Kim, E. J.,
& Lee, J. (2020).
Clinical
Significance of
Timing of
Intubation in
Critically Ill
Patients with
COVID-19: A
Multi-Center
Retrospective
Study. Journal of
Clinical
Medicine, 9(9),
2847.http://dx.doi.
org/10.3390/jcm90
92847

To determine if
early intubation is
associated with the
survival of
COVID-19
patients with acute
respiratory distress
syndrome

47 adult patients
diagnosed with
COVID-19

Retrospective

Early intubation:
Intubated/mechanically
ventilated and meeting
ARDS criteria on the
same day as intubation
(within 24 hours) and

Of the 47 patients, 23 (48.9%)
patients were intubated on the
day of meeting ARDS criteria
(early intubation), while 24
(51.1%) were not initially
intubated. Of those eight
patients were never intubated
during their in-hospital course.
21 patients (44.7%) died while
in the hospital.

Early intubation was not
associated with improved
survival

Level IV

Pubmed

Three tertiary
referral hospitals in
Daegu, Korea
between 2/17/204/23/20

Initially non-intubated:
Not intubated on the day
of meeting ARDS
criteria.
The initially nonintubated group was
divided further into two
subgroups: (A) never
intubated (B) late
intubation defined by not
being intubated on day of
ARDS diagnosis

No significant difference in inhospital mortality rate was
found between the early group
and initially non-intubated
groups (56.5% vs. 33.3%, p =
0.110)
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Matta, A.,
Chaudhary, S., Lo,
K.B., DeJoy III,
R., Gul, F., Torres,
R., Chaisson, N. &
Patarroyo-Aponte,
G. (2020). Timing
of intubation and
its implications on
outcomes in
critically ill
patients with
coronavirus
disease 2019
infection. Critical
care
explorations, 2(10
). https://wwwncbi-nlm-nihgov.wsuproxy.mn
pals.net/pmc/articl
es/PMC7587415/

To “evaluate the
association
between timing of
intubation and
outcomes among
critically ill
patients with
COVID-19” (p.1).

128 ICU patients
diagnosed with
COVID-19 from
March 15, 2020 to
May 30, 2020

Observational
Retrospective
Study

Early intubation was
defined as intubation
either at hospital
admission or less than 2
days since the onset of
increased oxygen
requirements defined by
requiring more than 50%
FIO2.

Timing of intubation does not
seem to be significantly
associated with poor clinical
outcomes in critically ill
patients with COVID-19. The
timing of intubation seems to
be driven mainly by disease
severity and rate of progression

Relatively small cohort of
patients

Level IV

Pubmed

Einstein Medical
Center,
Philadelphia, PA
.

Late intubation greater
than or equal to 2 days
following the onset of
increased oxygen
requirements defined by
requiring more than 50%
FIO2.

The patients who required
early intubation had
significantly higher Sequential
Organ Failure Assessment
scores at admission (6.51 vs
3.48; p ≤ 0.0001)
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Pandya, A., Kaur,
N.A., Sacher, D.,
O'Corragain, O.,
Salerno, D., Desai,
P., Sehgal, S.,
Gordon, M.,
Gupta, R.,
Marchetti, N., &
Zhao, H. (2021).
Ventilatory
mechanics in early
vs late intubation
in a cohort of
coronavirus
disease 2019
patients with
ARDS: a single
center’s
experience. Chest,
159(2), 653-656.
https://europepmcorg.wsuproxy.mnp
als.net/articles/pm
c7456835/bin/mm
c1.pdf

To examine
ventilator
mechanics in early
versus late
intubation for
patients with
COVID 19

Seventy-five
COVID-19 patients
Hospitalized
between February
and May 2020.

Retrospective
Study

Early intubation was
intubation within the first
<1.27 days of admission

Late intubation (median, day 4)
was associated with longer
ICU length of stay and longer
duration of mechanical
ventilation than early
intubation (median, day 0).

Patients intubated who had
late intubation appear to
have worse compliance or
ventilator ratio with
potentially higher mortality.

Level IV

GoogleScholar

Temple University
Hospital,
Phiadephia, PA

Late intubation was
intubation within >1.27
days of admission

Non survivors had a longer
time to intubation than
survivors in our cohort.

Difficult to determine if the
decline in lung compliance
is due to disease progression
or the presence of self
induced lung injury

29
Citation/Search
Engine

Purpose/Objective

Study
Population/Sample/
Setting

Design

Variables/Instruments

Results(s)/Major or Findings

Implications/Critique

Level of
Evidence

Papoutsi, E.,
Giannakoulis, V.
G., Xourgia, E.,
Routsi, C.,
Kotanidou, A., &
Siempos, I. I.
(2021). Effect of
timing of
intubation on
clinical outcomes
of critically ill
patients with
COVID-19: a
systematic review
and meta-analysis
of non-randomized
cohort
studies. Critical
Care, 25(1), 1-9.
https://linkspringercom.wsuproxy.mn
pals.net/article/10.
1186/s13054-02103540-6

To investigate the
effect, if any, of
timing of
intubation on
clinical outcomes
of critically ill
patients with
COVID-19

8944 critically ill
patients
(hospitalized in the
ICU) with COVID19

Systematic review
and meta-analysis.

Early intubation –
intubation after 24 hours
from intensive care unit
admission

“There was no statistically
detectable difference on allcause mortality between
patients undergoing early
versus late intubation” (p.1).

Of almost 9000 patients,
timing of intubation had no
effect on mortality and
morbidity of critically ill
patients with COVID-19.

Level I

Google Scholar

ICU setting in
Africa, Asia,
Europe and
America

Late intubation –
intubation after 24 hours
of ICU admission.

Of 8944 patients there were
3981 recorded deaths; 45.4%
were early intubation versus
39.1% were late intubations;
RR 1.07, 95% CI 0.99–
1.15, p = 0.08
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Rhee, C.J.A.,
Castaneda, C.,
Karass, M., Abe,
O., Elshakh, H.,
Kim, M., Sajid, F.,
Ju, T., Voronina,
A., Al-Ghrairi, A.
& El Marabti, E.
(2020). Timing of
intubation and
outcome in the
covid-19
pandemic:
challenging the
concept of
permissive
hypoxemia. Chest,
158(4), A630.
https://journal.ches
tnet.org/article/S0
0123692(20)32780X/fulltext

Examine the
preoxygenation
state of patients
diagnosed with
COVID-19 prior
to intubation and
the implications of
intubation on
clinical outcomes.

192 patients
diagnosed with
COVID-19 between
March 15, 2020 and
April 15, 2020

Retrospective
study

Preoxygenation levels of
all intubated patients

Decreased oxygenation and P/F
ratios before intubation were
associated with an increase in
peri-intubation complications,
such as cardiac arrest

Clinical outcome was
further impacted by the
restriction on
preoxygenation of the
patients before intubation,
given its risk of viral
aerosolization

Level IV

Ebscohost

Queens, New York

Subsequent groups
identified included
patients with normal
preoxygenation levels,
and those with
significantly lower periintubation oxygen levels
P/F ratio of the two
groups were also looked
at. The P/F ratio is the
arterial pO2 from the
ABG divided by the FIO2

32 out of 192 patients (16.7%)
with peri-intubation cardiac
arrest demonstrated
significantly lower preoxygenation levels(p = 0.03)
These 32 patients also
demonstrated more days with
COVID-19 symptoms prior to
intubation (p = 0.004).
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Shashikumar, S. P.
(2021).
Development and
prospective
validation of a
deep learning
algorithm for
predicting need for
mechanical
ventilation. Chest.,
159(6), 2264–
2273.
https://doi.org/10.
1016/j.chest.2020.
12.009

To develop,
externally
validated and
prospectively test
a transparent deep
learning algorithm
for predicting, 24
hours in advance,
the need for
mechanical
ventilation in
hospitalized
patients with
COVID-19 by
using a
field of machine
learning (ML)
which is an
artificial
intelligence that
automates
analytical model
building to
identify patterns in
data to predict
outcomes

402 adult patients
diagnosed with
COVID-19
3,888 general ICU
patients
January 01, 2016, to
December 31, 2019
(Retrospective
cohorts)
February 10, 2020
to May 4, 2020
(Prospective
cohorts)

Observational
cohort study

Variable used in
guidance of intubation
included were heart rate,
pulse oximetry,
temperature, systolic
blood pressure, mean
arterial pressure, diastolic
blood pressure,
respiration rate and end
tidal carbon dioxide. Lab
values included
bicarbonate, measure of
excess bicarbonate,
fraction of inspired
oxygen or FIO2, pH,
partial pressure of carbon
dioxide from arterial
blood, oxygen saturation
from arterial blood,
aspartate transaminase,
blood urea nitrogen,
alkaline phosphatase,
potassium, total bilirubin,
troponin, hematocrit,
hemoglobin, partial
thromboplastin time,
leukocyte count,
fibrinogen, and platelets
along with demographic
variables. An automated
program gathers the date
from electronic medical
record, scores it and
predicts when a patient
likely needs mechanical
ventilation in the next 24
hours. Patients with a
score of 0 were unlikely
to need mechanical
ventilation in the next 24
hours where a patient
with a score closer to 1
was likely to need to be

intubated in the next 24 hours.

Pubmed

University of
California San
Diego Health and
Massachusetts
General Hospital

A traditional algorithm
improves traditional clinical
criteria to predict need for
mechanical intubation
The area under the ROC curve
model was used to check
reliability of the prediction, the
higher the score the better.
For general ICU population
0.882 and 0.918 for patients
with COVID-19 when using
the 24- hour prediction horizon
compared to the ROX score
which was in the range of
0.772-0.810

Implications/Critique

Level of
Evidence

Level IV
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Siempos, I.I.,
Xourgia, E.,
Ntaidou, T.K.,
Zervakis, D.,
Magira, E.E.,
Kotanidou, A.,
Routsi, C. &
Zakynthinos, S.G.
(2020). Effect of
early versus
delayed or no
intubation on
clinical outcomes
of patients with
COVID-19: An
observational
study. Frontiers in
medicine, 7.
https://www-ncbinlm-nihgov.wsuproxy.mn
pals.net/pmc/articl
es/PMC7785771/

To determine the
optimal timing of
initiation of
invasive
mechanical
ventilation in
patients with acute
hypoxemic
respiratory failure
due to COVID-19

42 ICU patients
with COVID-19

Retrospective
single center study

Early intubation group
Delayed or no intubation
group: patients receiving
non-rebreather mask for
equal to or more than 24
hours or high-flow nasal
oxygen for any period of
time or non-invasive
mechanical ventilation
for any period of time in
an attempt to avoid
mechanical intubation

Early intubation, as opposed to
delayed or no intubation, was
not associated with worse
clinical outcomes, such as
mortality 21% vs 33%,
ventilator-free days 3 versus 2
or out of ICU days compared
to delayed or no intubation.

Early intubation doesn’t
help

Level IV

Cochrane library

March 11, 2020 and
April 15, 2020
Evangelismos
Hospital, Athens,
Greece
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(2021).
Conservative
management of
COVID-19
associated
hypoxaemia. ERJ
Open
Research, 7(1).
https://openres.ersj
ournals.com/conte
nt/7/1/000262021.abstract

To evaluate a
predefined
protocol for
restrictive use of
invasive
ventilation where
the decision to
intubate was based
on the clinical
presentation and
oxygen content
rather than on the
degree of
hypoxemia.

78 adult patients
diagnosed with
COVID-19

Retrospective
study analysis

Group 1 received
supplemental oxygen via
nasal cannula

Overall mortality was 7.7% of
all groups
93% of all patients studied
were discharged on room air
Mortality of intubated patients
was 50%

Allowing patients to become
hypoxemic and basing
intubation on clinical
presentation decreased
mortality and showed a
decrease in the rate of
intubation

Level IV

Googlescholar

Kloster Grafschaft
Hospital and
Bethanien Moers
Hospital

Group 2 received nasal
high-flow continuous
positive airway pressure
(CPAP), noninvasive
ventilation or a
combination of the above
mentioned methods
Group 3 received
intubation
They used Horowitz
index or P/F ration to
assess lung function,
helpful to determine
extent of damage to
lungs. Which is a
calculation that uses the
partial pressure
oxygenation and fraction
of inspired oxygen.

The Horowitz index:
Group 1: 216±8
Group 2: 157±13
Group 3: 106±15
The Horowitz index or P/F
rations of greater than 300 is
considered not ARDS, 200300 is considered to be mild
ARDS, 100-200 moderate
ARDS and less than 100 severe
ARDS
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https://www-ncbinlm-nihgov.wsuproxy.mn
pals.net/pmc/articl
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To report the cases
of critical patients
receiving
mechanical
ventilation in
Wuhan, China

40 adult pateints
diagnosed with
COVID-19

Retrospective
Study

Acute Physiology and
Chronic Health
Evaluation II (APACHE
II) score is based form 0100 the higher the score
the more the mortality
rate increases

Zhongnan and
Wuhan Union
Hospital in Wuhan,
China

pneumonia severity index
(PSI) score estimated the
severity of pneumonia to
predict mortality risk

This study was performed
early on in the COVID-19
pandemic, prior to when
preoxygenation data was
allowed of COVID-19
patients due to risk of
aerosol particles.
Early intubation was found
beneficial in those with low
APACHE II and PSI scores

Level V

To discuss the
timing of
intubation in
patients diagnosed
with COVID- 19
patients.

“Early initial intubation after
NIV/HFNC could have a
beneficial effect in reducing
mortality for critically ill
patients meeting IMV
indication. Considering
APACHE II and PSI scores
might help physicians in
decision making about timing
of intubation for curbing
subsequent mortality” (p.
2092).

Patients with 50 hours or
less of non-invasive
ventilation (NIV) or highflow nasal cannula
(HFNC)

67% of survivors and 61%
non survivors had APACHE II
scores of between 8 and 15 at
admission.

Googlescholar

January 1, 2020 to
March 10, 2020

Median PSI score was 78 in
survivors and 98 in
nonsurvivors
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To determine the
best treatment and
management in the
care of patients
diagnosed with
COVID-19

54 adult patients
diagnosed with
COVID- 19

Retrospective
Study

Number of days of
COVID-19 symptoms
Admitted days
Blood chemistry (ABG),
Patient age
Gender
Pulse oximetry

9 out of the 25 patients who
received early intubation died

Ebscohost

March to June
2020.
Crema Hospital in
Italy

12 out of the 23 who were
intubated late died
Late intubation was defined as
24 hours of non invasive
ventilation
No difference in mortality of
early or late intubations.
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Level IV
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Table 3
Levels of Evidence

Level of evidence (LOE)
Level I

Description
Evidence from a systematic review or metaanalysis of all relevant RCTs (randomized
controlled trial) or evidence-based clinical
practice guidelines based on systematic
reviews of RCTs or three or more RCTs of
good quality that have similar results.

Level II

Evidence obtained from at least one welldesigned RCT (e.g. large multi-site RCT).

Level III

Evidence obtained from well-designed
controlled trials without randomization (i.e.
quasi-experimental).

Level IV

Evidence from well-designed case-control or
cohort studies.

Level V

Evidence from systematic reviews of
descriptive and qualitative studies (metasynthesis).

Level VI

Evidence from a single descriptive or
qualitative study.

Level VII

Evidence from the opinion of authorities
and/or reports of expert committees.

(Ackley et al., 2008)
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APPENDIX A
VentNet Algorithm

(Shashikumar et al., 2020)
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APPENDIX B
Johns Hopkins Nursing Evidence-Based Practice Model

Practice Question
Step 1: Recruit interprofessional team
Step 2: Define the problem
Step 3: Develop and refine the EBP question
Step 4: Identify stakeholders
Step 5: Determine responsibility for project Leaders
Step 6: Schedule team meetings
Evidence
Step 7: Conduct internal and external search for evidence
Step 8: Appraise the level and quality of each piece of evidence
Step 9: Summarize the individual evidence
Step 10: Synthesize overall strength and quality of evidence
Step 11: Develop recommendations for change based on evidence synthesis
Translation:
Step 12: Determine fit, feasibility and appropriateness of recommendations
Step 13: Create action plan
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Step 14: Secure support and resources to implement action plan
Step 15: Implement action plan
Step 16: Evaluate outcomes
Step 17: Report outcomes to stakeholders
Step 18: Identify next steps
Step 19: Disseminate findings
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